0001144204-14-015047.txt : 20140312 0001144204-14-015047.hdr.sgml : 20140312 20140312134539 ACCESSION NUMBER: 0001144204-14-015047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140312 FILED AS OF DATE: 20140312 DATE AS OF CHANGE: 20140312 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN OORT DOUGLAS M CENTRAL INDEX KEY: 0001518733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 14686987 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 4 1 form466866_20140312014515-.xml X0306 4 2014-03-12 0 0001077183 NEOGENOMICS INC NEO 0001518733 VAN OORT DOUGLAS M C/O NEOGENOMICS, INC. 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL US 33913 1 1 0 0 Chairman and CEO Common Stock 2014-03-12 4 A 0 187500 1.05 A 991456 I Trust by Self Common Stock 2014-03-12 4 A 0 187500 1.05 A 187500 I By Conundrum Capital Partners, LLC Common Stock 8600 D Warrants (Right to Buy) 1.05 2014-03-12 4 A 0 375000 1.05 A 2009-03-16 2014-03-15 Common Stock 0 250000 D Stock Option (Right to buy) 1.71 2013-02-14 2017-02-14 Common Stock 0 800000 D Stock Option (Right to buy) 0.8 2009-12-31 2016-03-15 Common Stock 0 1000000 D Conundrum Capital Partners, LLC is a limited partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Condundrum Capital Partners, LLC. On March 16, 2009 Mr. VanOort was granted a warrant to purchase 625,000 shares. Of this total 375,000 shares became vested and exercisable and 250,000 shares are not vested and exercisable. On March 12, 2014 Mr. VanOort exercised 375,000 warrants and received 375,000 shares of NeoGenomics common stock. On February 14, 2012 Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date. On March 15, 2009 Mr. VanOort was granted options to purchase 1,000,000 shares. The grant was comprised of 500,000 time based options and 500,000 performance based options. The first date that vesting became available was December 31, 2009. /s/ Douglas M. VanOort 2014-03-12